Personalized Circulating tumor DNA as a Predictive Biomarker in High-Risk Early Stage Breast Cancer Treated With Neoadjuvant Chemotherapy Published Date September 22, 2026 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen
